|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash and cash equivalents (primarily related to VIEs) | ||||||||||||||||||||
| Receivables: | ||||||||||||||||||||
| Trade less allowance for credit losses of $476 and $308, respectively (primarily related to VIEs) | ||||||||||||||||||||
| Other | ||||||||||||||||||||
| Inventories | ||||||||||||||||||||
| Costs and estimated earnings in excess of billings on uncompleted contracts | ||||||||||||||||||||
| Prepaid expenses and other | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Investment in unconsolidated companies | ||||||||||||||||||||
| Deposits and other (primarily related to VIEs) | ||||||||||||||||||||
| Deferred income taxes | ||||||||||||||||||||
| Property, plant and equipment, net ($3,010,086 and $2,802,920 related to VIEs, respectively) | ||||||||||||||||||||
| Variable Interest Entity, Primary Beneficiary | ||||||||||||||||||||
| Total property, plant and equipment, net ($3,010,086 and $2,802,920 related to VIEs, respectively) | ||||||||||||||||||||
| Property, plant and equipment, net ($3,583,076 and $3,460,079 related to VIEs, respectively) | ||||||||||||||||||||
| Variable Interest Entity, Primary Beneficiary | ||||||||||||||||||||
| Total property, plant and equipment, net ($3,583,076 and $3,460,079 related to VIEs, respectively) | ||||||||||||||||||||
| Construction-in-process ($360,291 and $392,644 related to VIEs, respectively) | ||||||||||||||||||||
| Variable Interest Entity, Primary Beneficiary | ||||||||||||||||||||
| Total construction-in-process ($360,291 and $392,644 related to VIEs, respectively) | ||||||||||||||||||||
| Operating leases right of use ($24,671 and $17,236 related to VIEs, respectively) | ||||||||||||||||||||
| Variable Interest Entity, Primary Beneficiary | ||||||||||||||||||||
| Total operating leases right of use ($24,671 and $17,236 related to VIEs, respectively) | ||||||||||||||||||||
| Finance leases right of use (none related to VIEs) | ||||||||||||||||||||
| Variable Interest Entity, Primary Beneficiary | ||||||||||||||||||||
| Total finance leases right of use (none related to VIEs) | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND EQUITY | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable and accrued expenses | ||||||||||||||||||||
| Short term revolving credit lines with banks (full recourse) | ||||||||||||||||||||
| Revolving Credit Facility | ||||||||||||||||||||
| Total short term revolving credit lines with banks (full recourse) | ||||||||||||||||||||
| Commercial paper (less deferred financing costs of $14 and $17, respectively) | ||||||||||||||||||||
| Convertible senior notes (less deferred financing costs of $4,990) | ||||||||||||||||||||
| Billings in excess of costs and estimated earnings on uncompleted contracts | ||||||||||||||||||||
| Limited and non-recourse (primarily related to VIEs): | ||||||||||||||||||||
| Current portion of long-term debt: | ||||||||||||||||||||
| Limited and non-recourse (primarily related to VIEs) | ||||||||||||||||||||
| Senior Secured Notes | ||||||||||||||||||||
| Total limited and non-recourse (primarily related to VIEs) | ||||||||||||||||||||
| Full recourse | ||||||||||||||||||||
| Senior Unsecured Bonds | ||||||||||||||||||||
| Total full recourse | ||||||||||||||||||||
| Current portion of financing liability | ||||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||||
| Finance lease liabilities | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Limited and non-recourse (primarily related to VIEs and less deferred financing costs of $9,128 and $7,889, respectively) | ||||||||||||||||||||
| Long-term debt, net of current portion: | ||||||||||||||||||||
| Limited and non-recourse (primarily related to VIEs and less deferred financing costs of $15,131 and $13,488, respectively) | ||||||||||||||||||||
| Full recourse (less deferred financing costs of $3,657 and $4,248, respectively) | ||||||||||||||||||||
| Senior Unsecured Bonds | ||||||||||||||||||||
| Total full recourse (less deferred financing costs of $3,657 and $4,248, respectively) | ||||||||||||||||||||
| Convertible senior notes (less deferred financing costs of $18,545 and $4,103, respectively) | ||||||||||||||||||||
| Convertible Senior Notes | ||||||||||||||||||||
| Total convertible senior notes (less deferred financing costs of $18,545 and $4,103, respectively) | ||||||||||||||||||||
| Financing liability | ||||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||||
| Finance lease liabilities | ||||||||||||||||||||
| Liability associated with sale of tax benefits | ||||||||||||||||||||
| Deferred income taxes | ||||||||||||||||||||
| Liability for unrecognized tax benefits | ||||||||||||||||||||
| Liabilities for severance pay | ||||||||||||||||||||
| Asset retirement obligation | ||||||||||||||||||||
| Other long-term liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Redeemable noncontrolling interest | ||||||||||||||||||||
| Equity: | ||||||||||||||||||||
| The Company's stockholders' equity: | ||||||||||||||||||||
| Common stock, par value $0.001 per share; 200,000,000 shares authorized; 61,980,201 and 61,104,078 shares issued; 61,496,941 and 60,845,411 shares outstanding, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Treasury stock, at cost (483,260 and 258,667 shares held, respectively) | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||||||||||||
| Total stockholders' equity attributable to Company's stockholders | ||||||||||||||||||||
| Noncontrolling interest | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Total liabilities, redeemable noncontrolling interest and equity | ||||||||||||||||||||
Loading...